ENTX
Income statement / Annual
Last year (2024), Entera Bio Ltd.'s total revenue was $181.00 K,
and the percentage change from the previous year is not available.
In 2024, Entera Bio Ltd.'s net income was -$9.54 M.
See Entera Bio Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$181.00 K |
$0.00 |
$134.00 K |
$571.00 K |
$365.00 K |
$236.00 K |
$500.00 K |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$172.00 K
|
$56.00 K
|
$165.00 K
|
$373.00 K
|
$300.00 K
|
$448.00 K
|
$0.00
|
$43.00 K
|
$35.00 K
|
$28.00 K
|
| Gross Profit |
$9.00 K
|
-$56.00 K
|
-$31.00 K
|
$198.00 K
|
$65.00 K
|
-$212.00 K
|
$500.00 K
|
-$43.00 K
|
-$35.00 K
|
-$28.00 K
|
| Gross Profit Ratio |
0.05
|
0
|
-0.23
|
0.35
|
0.18
|
-0.9
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$4.50 M
|
$4.45 M
|
$5.78 M
|
$6.77 M
|
$6.38 M
|
$6.96 M
|
$8.52 M
|
$2.77 M
|
$2.65 M
|
$2.12 M
|
| General & Administrative Expenses |
$5.10 M
|
$0.00
|
$0.00
|
$5.69 M
|
$4.85 M
|
$0.00
|
$2.84 M
|
$8.58 M
|
$2.72 M
|
$1.59 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.10 M
|
$4.43 M
|
$7.25 M
|
$5.69 M
|
$4.85 M
|
$4.28 M
|
$2.84 M
|
$8.58 M
|
$2.72 M
|
$1.59 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$46.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$9.59 M
|
$8.88 M
|
$13.04 M
|
$12.42 M
|
$11.23 M
|
$11.24 M
|
$11.36 M
|
$11.34 M
|
$5.37 M
|
$3.70 M
|
| Cost And Expenses |
$9.77 M
|
$8.94 M
|
$13.20 M
|
$12.79 M
|
$11.53 M
|
$11.69 M
|
$11.36 M
|
$11.34 M
|
$5.37 M
|
$3.70 M
|
| Interest Income |
$58.00 K
|
$31.00 K
|
$83.00 K
|
$0.00
|
$0.00
|
$0.00
|
$34.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$29.00 K
|
$28.00 K
|
$84.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$46.00 K
|
$56.00 K
|
$64.00 K
|
$53.00 K
|
$63.00 K
|
$238.00 K
|
$54.00 K
|
$43.00 K
|
$35.00 K
|
$28.00 K
|
| EBITDA |
-$9.54 M |
-$8.80 M |
-$12.87 M |
-$12.16 M |
-$11.11 M |
-$10.47 M |
-$10.81 M |
-$11.05 M |
-$5.33 M |
-$3.67 M |
| EBITDA Ratio |
-52.7
|
0
|
-96.04
|
-21.3
|
-30.42
|
-44.38
|
-21.61
|
0
|
0
|
0
|
| Operating Income Ratio |
-52.96
|
0
|
-97.52
|
-21.4
|
-30.6
|
-48.53
|
-21.72
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$58.00 K
|
$80.00 K
|
$134.00 K
|
-$29.00 K
|
-$28.00 K
|
$659.00 K
|
$557.00 K
|
$146.00 K
|
$4.17 M
|
-$581.00 K
|
| Income Before Tax |
-$9.53 M
|
-$8.86 M
|
-$12.93 M
|
-$12.25 M
|
-$11.20 M
|
-$10.80 M
|
-$10.30 M
|
-$11.20 M
|
-$1.20 M
|
-$4.28 M
|
| Income Before Tax Ratio |
-52.64
|
0
|
-96.52
|
-21.45
|
-30.67
|
-45.74
|
-20.61
|
0
|
0
|
0
|
| Income Tax Expense |
$14.00 K
|
$29.00 K
|
$137.00 K
|
-$59.00 K
|
$20.00 K
|
$0.00
|
$0.00
|
-$146.00 K
|
$0.00
|
$0.00
|
| Net Income |
-$9.54 M
|
-$8.89 M
|
-$13.07 M
|
-$12.19 M
|
-$11.22 M
|
-$10.80 M
|
-$10.30 M
|
-$11.20 M
|
-$1.20 M
|
-$4.28 M
|
| Net Income Ratio |
-52.71
|
0
|
-97.54
|
-21.34
|
-30.73
|
-45.74
|
-20.61
|
0
|
0
|
0
|
| EPS |
-0.25 |
-0.31 |
-0.45 |
-0.47 |
-0.54 |
-0.9 |
-0.91 |
-1.31 |
-0.14 |
-0.36 |
| EPS Diluted |
-0.25 |
-0.31 |
-0.45 |
-0.47 |
-0.54 |
-0.9 |
-1.29 |
-0.94 |
-0.1 |
-0.36 |
| Weighted Average Shares Out |
$37.65 M
|
$29.01 M
|
$28.81 M
|
$26.13 M
|
$18.42 M
|
$12.15 M
|
$11.37 M
|
$8.57 M
|
$8.57 M
|
$11.90 M
|
| Weighted Average Shares Out Diluted |
$37.65 M
|
$29.01 M
|
$28.81 M
|
$26.13 M
|
$18.42 M
|
$12.15 M
|
$11.51 M
|
$11.90 M
|
$11.90 M
|
$11.90 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
